Axonics Inc (AXNX)
67.09
-0.04
(-0.06%)
USD |
NASDAQ |
May 31, 16:00
67.16
+0.07
(+0.10%)
After-Hours: 20:00
Axonics Research and Development Expense (Annual): 34.89M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 34.89M |
| December 31, 2022 | 34.41M |
| December 31, 2021 | 37.30M |
| December 31, 2020 | 29.06M |
| Date | Value |
|---|---|
| December 31, 2019 | 20.07M |
| December 31, 2018 | 19.40M |
| December 31, 2017 | 12.33M |
| December 31, 2016 | 12.51M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
20.07M
Minimum
2019
37.30M
Maximum
2021
31.14M
Average
34.41M
Median
2022
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp | 1.414B |
| Cutera Inc | 21.41M |
| Stereotaxis Inc | 10.27M |
| Electromed Inc | 0.916M |
| Myomo Inc | 2.636M |